Announcements Trials
Browse Landscape

Status

Recruiting 3Completed 3Unknown 1

Sponsor Class

OTHER 7

Study Type

Interventional 124Observational 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Colorectal Neoplasms 30Carcinoma, Non-Small-Cell Lung 9Carcinoma, Hepatocellular 7Breast Neoplasms 7Carcinoma, Renal Cell 6Lung Neoplasms 5Ovarian Neoplasms 4Colorectal Cancer Metastatic 3Colonic Neoplasms 3Adenocarcinoma of Lung 3Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Liver Neoplasms 2Financial Stress 2Brain Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Unspecified Adult Solid Tumor, Protocol Specific 1Unresectable Hepatocellular Carcinoma 1Surgical Wound Infection 1Non-Squamous Non-Small Cell Lung Cancer 1Neuroma, Acoustic 1Neurofibromatosis 2 1NSCLC 1Melanoma 1Kidney Neoplasms 1Hypertension 1Hemorrhage 1Glioblastoma 1Feasibility 1

Interventions

Sorafenib 20lenvatinib 18Hepatectomy 17Blood Specimen Collection 12Immune Checkpoint Inhibitors 11atezolizumab 9Liver Transplantation 9Surgical Procedures, Operative 7Radiofrequency Ablation 7Observation 7Bevacizumab 7regorafenib 5gadolinium ethoxybenzyl DTPA 5sintilimab 4donafenib 4camrelizumab 4Radiotherapy 4Magnetic Resonance Spectroscopy 4tislelizumab 3spartalizumab 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Mass Spectrometry 3Immunohistochemistry 3Doxorubicin 3Angiogenesis Inhibitors 3toripalimab 2pembrolizumab 2entecavir 2apatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Observational × Carcinoma, Hepatocellular × Bevacizumab × Clear all
NCT07610551 2026-05-28

Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular Carcinoma

Air Force Military Medical University, China

Recruiting
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04862949 2025-12-12

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

CHA University

Completed
131 enrolled 8 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT05197504 2025-09-05

HCC

CHA University

Completed
166 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05713994 2025-03-25

CCGLC-001

Tongji Hospital

Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05717738 2024-06-13

CCGLC-008

Tongji Hospital

Recruiting
300 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05173298 2024-02-07

HCC

CHA University

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06199297 2024-01-26

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Sun Yat-sen University

Completed
188 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡